<DOC>
	<DOCNO>NCT00702988</DOCNO>
	<brief_summary>The objective trial evaluate whether Org 36286 treatment induction multifollicular growth woman undergo controlled ovarian stimulation ( COS ) vitro fertilization ( IVF ) intracytoplasmatic sperm injection ( ICSI ) safe pregnant subject offspring .</brief_summary>
	<brief_title>Pregnancy &amp; Neonatal Follow-up Ongoing Pregnancies Established During Clinical Trial 38826 ( Study 38827 ) ( P06056 ) ( COMPLETED )</brief_title>
	<detailed_description>This open , prospective follow-up trial monitor pregnancy , delivery , neonatal outcome woman become pregnant Trial 38826 . For trial , study specific assessment require , information obtain standard practice use .</detailed_description>
	<criteria>Subjects participate Trial 38826 become pregnant ( confirm USS beyond 10 week ET ) receive least one dose either Org 36286 PuregonÂ® ; Able willing give write informed consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Neonatal outcome</keyword>
	<keyword>Congenital malformation</keyword>
	<keyword>In-Vitro Fertilization</keyword>
	<keyword>Controlled ovarian stimulation</keyword>
	<keyword>Follow-up</keyword>
</DOC>